Adaptive Designs in Clinical Trials
April 20 - 21, 2015 - London UKSMi Group Ltd
mmugema@smi-online.co.uk
Phone:020 7827 6072
With a serious decline in only 1 in 10 drugs successfully passing phase II/III of clinical trials, there is increasing pressure to bring drugs quickly into the market and reduce the cost of drug development. This conference offers the perfect platform to hear strategies such as Seamless Adaptive Designs and Group –Sequential Adaptive Designs which are areas that improve the efficiency of drug development. This conference will review the drug development process and provide a detailed discussion of how adaptive designs are changing the development process. The main focus of the presentation will be to explore the role of adaptive sample sizing; in particular, why it is important to consider the need to reassess sample sizes during the course of a trial.